Neoadjuvant Herceptin recommended for locally advanced breast cancer

29 January 2010 | by Tony James Print this article Comments Share this article
Adding neoadjuvant trastuzumab to chemotherapy should be considered in women with HER2-positive locally advanced breast cancer, the European NOAH trial has concluded....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites